GO,Function,Proteins,Gene Name,Ontology group,Count of protein,Number of proteins detected within the genome,GO frequency within the dataset (%),GO frequency within the genome (%),P-Value,P-Values_BH
GO:0005739,mitochondrion,P23004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q29RK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3SZI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)O02691(Evidence code:ISS/Database source:UniProtKB:O08756)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00125(Evidence code:ISS/Database source:UniProtKB:Q9D0M3)P00428(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P31800(Evidence code:ISS/Database source:UniProtKB:Q9CZ13)P05631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P45879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P13620(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q58DR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P23935(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P42029(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00432(Evidence code:IBA/Database source:PANTHER:PTN000157252)Q2TBV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P52505(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q58DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q29RZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00426(Evidence code:ISS/Database source:UniProtKB:P12787)P00366(Evidence code:ISS/Database source:UniProtKB:P26443)Q32LL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3T165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P20000(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P13619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P12344(Evidence code:ISS/Database source:UniProtKB:P00507)P13184(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P02721(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1MDS3(Evidence code:IEA/Database source:UniProtKB:Q16822|ens)Q64L89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q5E9F1(Evidence code:IEA/Database source:GO:0051561)P31039(Evidence code:ISS/Database source:UniProtKB:P31040), UQCRC2 CS IVD HSD17B10 COX4I1 CYC1 COX5B UQCRC1 ATP5C1 VDAC1 ATP5H SUCLG1 NDUFA5 NDUFA8 CYCS CAT ETFB NDUFAB1 ECHS1 ATP5J2 ACAT1 COX5A GLUD1 STOML2 PHB ALDH2 ATP5F1 LETM1 GOT2 COX7A2 C1QBP ATP5J PCK2 MGST1 BCAP31 SDHA,CC,36,36 of 380,40.45,9.47,1.223E-38,6.801E-36
GO:0016020,membrane,P23004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P11456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q64L89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P05631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P31039(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00428(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1L1H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YY49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8PVV5(Evidence code:IEA/Database source:InterPro:IPR001285|I)Q32LL2(Evidence code:IEA/Database source:InterPro:IPR001972)P13620(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2YDL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P13619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T165(Evidence code:IEA/Database source:InterPro:IPR000163)Q5E9F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI36(Evidence code:IEA/Database source:InterPro:IPR001733)P13184(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q6QUN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P45879(Evidence code:ISS/Database source:UniProtKB:Q60932)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q673L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EA68(Evidence code:IEA/Database source:InterPro:IPR002208)P23935(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8MJ82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFT6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P12344(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P02721(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2NL04(Evidence code:IEA/Database source:InterPro:IPR008056)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00426(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KID7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V888(Evidence code:IEA/Database source:InterPro:IPR003378)P31800(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6H7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T133(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P00125(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PJQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P42029(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q6Y1E2(Evidence code:IEA/Database source:InterPro:IPR008253), UQCRC2 M6PR MGST1 ATP5C1 SSR1 SDHA COX5B CD1B3 SURF4 SYPL1 STOML2 ATP5H FKBP11 ATP5F1 PHB BCAP31 SEC11C COX7A2 TREM1 VDAC1 BoLA C5AR1 SEC61A1 NDUFA5 lman1 COX4I1 TMED7 ATP5J2 GOT2 ARL6IP5 ATP5J TAPBP C1QBP COX5A LETM1 TMEM43 OSTC COPG UQCRC1 LOC789567 LRRC59 TMED9 CYC1 PGRMC2 NDUFA8 PLP2,CC,46,46 of 1837,51.69,2.5,1.545E-24,4.294E-22
GO:0005743,mitochondrial inner membrane,P13184(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P31039(Evidence code:ISS/Database source:UniProtKB:Q0QF01)P00125(Evidence code:ISS/Database source:UniProtKB:Q9D0M3)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P31800(Evidence code:ISS/Database source:UniProtKB:Q9CZ13)P05631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P00366(Evidence code:ISS/Database source:UniProtKB:P26443)P23935(Evidence code:IEA/Database source:InterPro:IPR006806)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P13620(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202)P02721(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P13619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P23004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1)Q3T165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P12344(Evidence code:ISS/Database source:UniProtKB:P05202)P00428(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P00426(Evidence code:IEA/Database source:InterPro:IPR003204|I)P42029(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999), COX7A2 SDHA CYC1 ATP5J2 UQCRC1 ATP5C1 GLUD1 NDUFA5 COX4I1 ATP5H LETM1 ATP5J ATP5F1 UQCRC2 STOML2 PHB GOT2 COX5B COX5A NDUFA8,CC,20,20 of 215,22.47,9.3,1.263E-22,2.34E-20
GO:0055114,oxidation-reduction process,Q3SZI8(Evidence code:IEA/Database source:InterPro:IPR006089|I)P20000(Evidence code:IEA/Database source:InterPro:IPR015590|I)P52505(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P00125(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)A6H7H3(Evidence code:IEA/Database source:GO:0016491)P00366(Evidence code:IEA/Database source:InterPro:IPR006095|I)P31039(Evidence code:IEA/Database source:InterPro:IPR003952|I)P42029(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)Q2TBV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I)Q3MHW4(Evidence code:IEA/Database source:InterPro:IPR023753)P23935(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P31800(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)O02691(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P23004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249), IVD ALDH2 NDUFAB1 CYC1 LOC789567 GLUD1 SDHA NDUFA8 ETFB CAT SQRDL NDUFA5 UQCRC1 CYCS HSD17B10 UQCRC2,BP,16,16 of 162,17.98,9.88,6.52E-19,9.062E-17
GO:0005783,endoplasmic reticulum,Q5E9X4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5E983(Evidence code:IEA/Database source:UniProtKB:P24534|ens)Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q80WW9)A7YY49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5EA68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2KI36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2KID7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QLP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q58DQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q148K7(Evidence code:IEA/Database source:InterPro:IPR010483)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417)Q3T133(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A4IFT6(Evidence code:IEA/Database source:UniProtKB:Q9Y3B3|ens)Q3T0L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q64L89(Evidence code:ISS/Database source:UniProtKB:P08011), LRRC59 EEF1B DDRGK1 SURF4 SEC61A1 ARL6IP5 SEC11C OSTC SSR1 RPL6 LRPAP1 BCAP31 TMED9 TMED7 ERP44 MGST1,CC,16,16 of 220,17.98,7.27,5.928E-17,6.592E-15
GO:0016021,integral component of membrane,P11456(Evidence code:IEA/Database source:InterPro:IPR000296)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P45879(Evidence code:IEA/Database source:InterPro:IPR030270)Q6Y1E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2NL04(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4IFT6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q2KID7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q64L89(Evidence code:ISS/Database source:UniProtKB:P08011)Q1L1H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2YDL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417)Q3T133(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6H7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QLP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P00125(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q6QUN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI36(Evidence code:IEA/Database source:InterPro:IPR019756|I)A8PVV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YY49(Evidence code:IEA/Database source:InterPro:IPR002995)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5PJQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8MJ82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812), M6PR ATP5J2 VDAC1 PLP2 TAPBP TMED7 LRRC59 C5AR1 OSTC MGST1 CD1B3 TMEM43 SEC61A1 FKBP11 BCAP31 TMED9 LOC789567 SSR1 COX4I1 CYC1 TREM1 SEC11C SYPL1 LETM1 BoLA SURF4 ARL6IP5 PGRMC2 lman1,CC,29,29 of 1299,32.58,2.23,1.488E-15,1.379E-13
GO:0070469,respiratory chain,P52505(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P42029(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P23004(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P23935(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P00125(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P31800(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679), NDUFAB1 NDUFA8 CYCS UQCRC2 NDUFA5 CYC1 UQCRC1,CC,7,7 of 10,7.87,70,3.034E-14,2.41E-12
GO:0005759,mitochondrial matrix,Q58DM8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P00366(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58DR8(Evidence code:IBA/Database source:PANTHER:PTN000122014)Q3SZI8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P20000(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P52505(Evidence code:IDA/Database source:)P12344(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBV3(Evidence code:ISS/Database source:UniProtKB:P38117)Q29RK1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0B6(Evidence code:IEA/Database source:InterPro:IPR003428|I), ECHS1 GLUD1 SUCLG1 IVD ALDH2 NDUFAB1 GOT2 ETFB CS C1QBP,CC,10,10 of 111,11.24,9.01,4.106E-12,2.854E-10
GO:0005840,ribosome,Q58DW5(Evidence code:IEA/Database source:InterPro:IPR005485)Q2TBQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q58DT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q5E9E6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q58DQ3(Evidence code:IEA/Database source:InterPro:IPR000915|I)Q56JX8(Evidence code:IEA/Database source:InterPro:IPR000589|I)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I), RPL5 RPL7A RPL7 RPL10A RPL6 RPS13 RPL8,CC,7,7 of 26,7.87,26.92,6.392E-12,3.949E-10
GO:0005789,endoplasmic reticulum membrane,Q5EA68(Evidence code:ISS/Database source:UniProtKB:P61619)Q6Y1E2(Evidence code:IBA/Database source:PANTHER:PTN000512431)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens)Q64L89(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YY49(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T133(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KI36(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLP7(Evidence code:IEA/Database source:InterPro:IPR005595)Q5E9F1(Evidence code:IBA/Database source:PANTHER:PTN000294723), SEC61A1 PLP2 ARL6IP5 ERP44 MGST1 SURF4 LRRC59 TMED9 SEC11C SSR1 BCAP31,CC,11,11 of 244,12.36,4.51,4.074E-10,2.265E-08
GO:0005751,mitochondrial respiratory chain complex IV,P23004(Evidence code:IEA/Database source:UniProtKB:P22695|ens)A5PK67(Evidence code:IBA/Database source:PANTHER:PTN001023184)P00423(Evidence code:IEA/Database source:UniProtKB:P13073|ens)P00428(Evidence code:IBA/Database source:PANTHER:PTN000012880)P00426(Evidence code:IEA/Database source:UniProtKB:P20674|ens), UQCRC2 MGC165862 COX4I1 COX5B COX5A,CC,5,5 of 12,5.62,41.67,1.108E-09,5.602E-08
GO:0022625,cytosolic large ribosomal subunit,Q2TBQ5(Evidence code:IBA/Database source:PANTHER:PTN000559990)Q58DW5(Evidence code:IBA/Database source:PANTHER:PTN000601661)Q58DQ3(Evidence code:ISS/Database source:UniProtKB:Q02878)Q3T0S6(Evidence code:IBA/Database source:PANTHER:PTN000343558)Q5E9E6(Evidence code:IEA/Database source:UniProtKB:P62906|ens)Q58DT1(Evidence code:IBA/Database source:PANTHER:PTN000897517), RPL7A RPL5 RPL6 RPL8 RPL10A RPL7,CC,6,6 of 45,6.74,13.33,8.686E-09,3.991E-07
GO:0005753,mitochondrial proton-transporting ATP synthase complex,P02721(Evidence code:IEA/Database source:UniProtKB:P18859|ens)P05631(Evidence code:IEA/Database source:UniProtKB:P36542|ens)P13620(Evidence code:IDA/Database source:)Q28851(Evidence code:IEA/Database source:UniProtKB:P56134|ens)P13619(Evidence code:ISS/Database source:UniProtKB:P24539), ATP5J ATP5C1 ATP5H ATP5J2 ATP5F1,CC,5,5 of 20,5.62,25,9.331E-09,3.991E-07
GO:0003723,RNA binding,F1MXI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q58DT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2TBQ5(Evidence code:IBA/Database source:PANTHER:PTN000559990)P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR023672)Q58DQ3(Evidence code:IBA/Database source:PANTHER:PTN000076315)Q3ZC44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SZF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A2VDN6(Evidence code:IEA/Database source:InterPro:IPR000061|I)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)Q5E9E6(Evidence code:IEA/Database source:InterPro:IPR002143)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q58DW5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694), MATR3 RPL7 RPL7A HNRNPA1 RPL8 RPL6 HNRNPAB HNRNPH2 SF3A1 SAMHD1 RPL10A DDX39B RPL5,MF,13,13 of 520,14.61,2.5,1.139E-08,4.272E-07
GO:0004129,cytochrome-c oxidase activity,P00423(Evidence code:IEA/Database source:InterPro:IPR004203|I)P00426(Evidence code:IEA/Database source:InterPro:IPR003204|I)A5PK67(Evidence code:IBA/Database source:PANTHER:PTN001023184)P13184(Evidence code:IEA/Database source:InterPro:IPR003177|I)P00428(Evidence code:IBA/Database source:PANTHER:PTN000012880), COX4I1 COX5A MGC165862 COX7A2 COX5B,MF,5,5 of 21,5.62,23.81,1.152E-08,4.272E-07
GO:0045263,"proton-transporting ATP synthase complex, coupling factor F(o)",P13620(Evidence code:IEA/Database source:UniProtKB-KW:KW-0138)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0138)P02721(Evidence code:IEA/Database source:UniProtKB-KW:KW-0138)P13619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0138), ATP5H ATP5J2 ATP5J ATP5F1,CC,4,4 of 11,4.49,36.36,8.459E-08,0.000002767
GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",P00423(Evidence code:IBA/Database source:PANTHER:PTN000076140)P00428(Evidence code:IBA/Database source:PANTHER:PTN000012880)P00426(Evidence code:IBA/Database source:PANTHER:PTN000367750)P62894(Evidence code:IBA/Database source:PANTHER:PTN000238899), COX4I1 COX5B COX5A CYCS,BP,4,4 of 11,4.49,36.36,8.459E-08,0.000002767
GO:0043209,myelin sheath,P13619(Evidence code:IEA/Database source:UniProtKB:Q9CQQ7|ens)P00426(Evidence code:IEA/Database source:UniProtKB:P12787|ens)Q3T165(Evidence code:IEA/Database source:UniProtKB:P67778|ens)P12344(Evidence code:IEA/Database source:UniProtKB:P05202|ens)P05631(Evidence code:IEA/Database source:UniProtKB:Q91VR2|ens)P23004(Evidence code:IEA/Database source:UniProtKB:Q9DB77|ens), ATP5F1 COX5A PHB GOT2 ATP5C1 UQCRC2,CC,6,6 of 71,6.74,8.45,1.071E-07,0.000003307
GO:0006412,translation,Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)Q56JX8(Evidence code:IEA/Database source:InterPro:IPR000589|I)Q5E9E6(Evidence code:IEA/Database source:InterPro:IPR002143)Q2TBQ5(Evidence code:IBA/Database source:PANTHER:PTN000559990)Q5E983(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q58DW5(Evidence code:IEA/Database source:InterPro:IPR005485)Q58DQ3(Evidence code:IEA/Database source:InterPro:IPR000915|I), RPL8 RPS13 RPL10A RPL7A EEF1B RPL5 RPL6,BP,7,7 of 130,7.87,5.38,1.754E-07,0.000005134
GO:0009055,electron transfer activity,P31039(Evidence code:IBA/Database source:PANTHER:PTN000180228)P00125(Evidence code:IEA/Database source:InterPro:IPR002326|I)Q2TBV3(Evidence code:IEA/Database source:InterPro:IPR000049|I)P13184(Evidence code:IEA/Database source:InterPro:IPR003177)P62894(Evidence code:IEA/Database source:InterPro:IPR002327|I), SDHA CYC1 ETFB COX7A2 CYCS,MF,5,5 of 46,5.62,10.87,3.872E-07,0.00001076
GO:0042776,mitochondrial ATP synthesis coupled proton transport,P00428(Evidence code:IBA/Database source:PANTHER:PTN000012880)Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1)P00125(Evidence code:IBA/Database source:PANTHER:PTN000030137), COX5B STOML2 CYC1,BP,3,3 of 3,3.37,100,4.402E-07,0.00001165
GO:0002181,cytoplasmic translation,Q3T0S6(Evidence code:IBA/Database source:PANTHER:PTN000343556)Q58DQ3(Evidence code:ISS/Database source:UniProtKB:Q02878)Q5E9E6(Evidence code:IEA/Database source:UniProtKB:P62906|ens)Q58DT1(Evidence code:IBA/Database source:PANTHER:PTN000897517), RPL8 RPL6 RPL10A RPL7,BP,4,4 of 20,4.49,20,6.449E-07,0.0000163
GO:0015986,ATP synthesis coupled proton transport,P13620(Evidence code:IEA/Database source:InterPro:IPR008689|I)P02721(Evidence code:IEA/Database source:InterPro:IPR008387|I)P05631(Evidence code:IEA/Database source:InterPro:IPR000131|I)P13619(Evidence code:IEA/Database source:InterPro:IPR008688|I), ATP5H ATP5J ATP5C1 ATP5F1,BP,4,4 of 21,4.49,19.05,0.000000766,0.00001852
GO:0005634,nucleus,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2HJ65(Evidence code:IEA/Database source:InterPro:IPR002119)P00423(Evidence code:IEA/Database source:UniProtKB:P13073|ens)Q58DW5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)P09867(Evidence code:ISS/Database source:UniProtKB:P09651)A5PK67(Evidence code:IEA/Database source:UniProtKB:Q9C002|ens)Q2TBP7(Evidence code:ISS/Database source:UniProtKB:Q99417)Q3SZF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00)Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021), PRMT6 DDX39B SF3A1 H2AFY COX4I1 RPL5 SAMHD1 S100A4 PHB HNRNPA1 MGC165862 MYCBP HNRNPH2 LRRC59 CREBL2 C1QBP,CC,16,16 of 1172,17.98,1.37,8.833E-07,0.00002046
GO:0016491,oxidoreductase activity,P20000(Evidence code:IEA/Database source:InterPro:IPR015590|I)O02691(Evidence code:IEA/Database source:InterPro:IPR020904)Q3MHW4(Evidence code:IEA/Database source:InterPro:IPR023753)P00366(Evidence code:IEA/Database source:InterPro:IPR006095|I)Q3SZI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A6H7H3(Evidence code:IEA/Database source:InterPro:IPR020904)P31039(Evidence code:IEA/Database source:InterPro:IPR003952|I)P52505(Evidence code:TAS/Database source:)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560), ALDH2 HSD17B10 SQRDL GLUD1 IVD LOC789567 SDHA NDUFAB1 CAT,MF,9,9 of 361,10.11,2.49,0.00000176,0.00003914
GO:0000276,"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)",P13620(Evidence code:IEA/Database source:InterPro:IPR008689|I)P13619(Evidence code:IEA/Database source:InterPro:IPR008688|I)P02721(Evidence code:IEA/Database source:InterPro:IPR008387|I), ATP5H ATP5F1 ATP5J,CC,3,3 of 8,3.37,37.5,0.000003593,0.00007682
GO:0003735,structural constituent of ribosome,Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)Q58DW5(Evidence code:IEA/Database source:InterPro:IPR005485)Q58DQ3(Evidence code:IEA/Database source:InterPro:IPR000915|I)Q58DT1(Evidence code:IBA/Database source:PANTHER:PTN000897517)Q5E9E6(Evidence code:IEA/Database source:InterPro:IPR002143)Q56JX8(Evidence code:IEA/Database source:InterPro:IPR000589|I), RPL8 RPL5 RPL6 RPL7 RPL10A RPS13,MF,6,6 of 138,6.74,4.35,0.00000425,0.00008752
GO:0046933,"proton-transporting ATP synthase activity, rotational mechanism",P05631(Evidence code:IEA/Database source:InterPro:IPR000131|I)P13620(Evidence code:IBA/Database source:PANTHER:PTN000294648)P13619(Evidence code:IBA/Database source:PANTHER:PTN000296496), ATP5C1 ATP5H ATP5F1,MF,3,3 of 10,3.37,30,0.0000062,0.0001189
GO:0005750,mitochondrial respiratory chain complex III,P31800(Evidence code:IBA/Database source:PANTHER:PTN000220240)P23004(Evidence code:IEA/Database source:UniProtKB:P22695|ens)P00125(Evidence code:IBA/Database source:PANTHER:PTN002231577), UQCRC1 UQCRC2 CYC1,CC,3,3 of 10,3.37,30,0.0000062,0.0001189
GO:0005730,nucleolus,Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q96LA8|ens)Q58DW5(Evidence code:ISS/Database source:UniProtKB:P46777)Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T147(Evidence code:IBA/Database source:PANTHER:PTN000618218)P68401(Evidence code:IEA/Database source:UniProtKB:P68402|ens)Q56JX8(Evidence code:IBA/Database source:PANTHER:PTN000223268), PRMT6 RPL5 H2AFY C1QBP DDX39B PAFAH1B2 RPS13,CC,7,7 of 232,7.87,3.02,0.000007085,0.0001313
GO:0032981,mitochondrial respiratory chain complex I assembly,P52505(Evidence code:ISS/Database source:UniProtKB:O14561)P23935(Evidence code:ISS/Database source:UniProtKB:Q16718)P42029(Evidence code:ISS/Database source:UniProtKB:P51970), NDUFAB1 NDUFA5 NDUFA8,BP,3,3 of 11,3.37,27.27,0.000007874,0.0001368
GO:0006122,"mitochondrial electron transport, ubiquinol to cytochrome c",P31800(Evidence code:IBA/Database source:PANTHER:PTN000220240)P00125(Evidence code:IBA/Database source:PANTHER:PTN000030137)P62894(Evidence code:IBA/Database source:PANTHER:PTN000238899), UQCRC1 CYC1 CYCS,BP,3,3 of 11,3.37,27.27,0.000007874,0.0001368
GO:1902600,proton transmembrane transport,A5PK67(Evidence code:IEA/Database source:GO:0004129)P00426(Evidence code:IEA/Database source:GO:0004129)P00423(Evidence code:IEA/Database source:GO:0004129)P13184(Evidence code:IEA/Database source:GO:0004129), MGC165862 COX5A COX4I1 COX7A2,BP,4,4 of 42,4.49,9.52,0.000009412,0.0001586
GO:0005737,cytoplasm,Q58DQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0S6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P68401(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q58DW5(Evidence code:ISS/Database source:UniProtKB:P46777)Q8MJ82(Evidence code:IEA/Database source:GO:0006888)Q5E983(Evidence code:IEA/Database source:UniProtKB:P24534|ens)Q2TBP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0B6(Evidence code:ISS/Database source:UniProtKB:O35796)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)O77775(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2YDL5(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q32LL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963), RPL6 RPL8 PAFAH1B2 ARL6IP5 PHB RPL5 lman1 EEF1B MYCBP C1QBP DDX39B NCF2 HNRNPA1 FKBP11 STOML2,CC,15,15 of 1304,16.85,1.15,0.00001294,0.0002116
GO:0020037,heme binding,P00125(Evidence code:IEA/Database source:InterPro:IPR002326|I)P00432(Evidence code:IEA/Database source:InterPro:IPR002226|I)A5PJQ6(Evidence code:IBA/Database source:PANTHER:PTN000031653)P62894(Evidence code:IEA/Database source:InterPro:IPR002327|I), CYC1 CAT PGRMC2 CYCS,MF,4,4 of 49,4.49,8.16,0.00001662,0.000264
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,A4IFT6(Evidence code:IEA/Database source:UniProtKB:Q9Y3B3|ens)Q3T133(Evidence code:IEA/Database source:UniProtKB:Q9BVK6|ens)Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens), TMED7 TMED9 ERP44,CC,3,3 of 15,3.37,20,0.0000175,0.0002703
GO:0006811,ion transport,P13620(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P05631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P13619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P02721(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P45879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406), ATP5H ATP5C1 ATP5F1 LETM1 ATP5J VDAC1 ATP5J2,BP,7,7 of 278,7.87,2.52,0.00002189,0.000329
GO:0005886,plasma membrane,Q1L1H6(Evidence code:IBA/Database source:PANTHER:PTN000422281)Q6Y1E2(Evidence code:IEA/Database source:UniProtKB:Q04941|ens)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)P45879(Evidence code:ISS/Database source:UniProtKB:P21796)Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q32LL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422281)P12344(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P68401(Evidence code:IEA/Database source:UniProtKB:P68402|ens), CD1B3 PLP2 PHB VDAC1 ARL6IP5 STOML2 C1QBP BoLA GOT2 PAFAH1B2,CC,10,10 of 630,11.24,1.59,0.000023,0.0003366
GO:0045277,respiratory chain complex IV,P00423(Evidence code:IDA/Database source:)P00428(Evidence code:IDA/Database source:)P00426(Evidence code:IDA/Database source:), COX4I1 COX5B COX5A,CC,3,3 of 17,3.37,17.65,0.00002435,0.0003471
GO:0022900,electron transport chain,P31039(Evidence code:IEA/Database source:InterPro:IPR014006)P13184(Evidence code:IEA/Database source:GO:0004129)Q2TBV3(Evidence code:IEA/Database source:GO:0009055)A5PK67(Evidence code:IEA/Database source:GO:0004129), SDHA COX7A2 ETFB MGC165862,BP,4,4 of 59,4.49,6.78,0.00003304,0.0004592
GO:0099132,ATP hydrolysis coupled cation transmembrane transport,P13619(Evidence code:IEA/Database source:GO:0046933)P05631(Evidence code:IEA/Database source:GO:0046933)P13620(Evidence code:IEA/Database source:GO:0046933), ATP5F1 ATP5C1 ATP5H,BP,3,3 of 23,3.37,13.04,0.00005481,0.0007433
GO:0006099,tricarboxylic acid cycle,Q58DR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0816)Q29RK1(Evidence code:IEA/Database source:InterPro:IPR019810)P31039(Evidence code:IEA/Database source:InterPro:IPR011281), SUCLG1 CS SDHA,BP,3,3 of 24,3.37,12.5,0.00006153,0.0008146
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,Q5E9M1(Evidence code:IEA/Database source:UniProtKB:O75915|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)P62894(Evidence code:IBA/Database source:PANTHER:PTN000943712), ARL6IP5 BCAP31 CYCS,BP,3,3 of 25,3.37,12,0.00006877,0.0008892
GO:0051289,protein homotetramerization,O02691(Evidence code:ISS/Database source:UniProtKB:Q99714)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens), HSD17B10 SAMHD1 CAT,BP,3,3 of 31,3.37,9.68,0.000124,0.001567
GO:0006851,mitochondrial calcium ion transmembrane transport,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202)Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1), LETM1 STOML2,BP,2,2 of 5,2.25,40,0.0001623,0.002005
GO:0005758,mitochondrial intermembrane space,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1)P42029(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P62894(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), STOML2 NDUFA8 CYCS,CC,3,3 of 35,3.37,8.57,0.0001733,0.002095
GO:0009986,cell surface,Q3T0B6(Evidence code:IEA/Database source:UniProtKB:Q07021|ens)P12344(Evidence code:ISS/Database source:UniProtKB:P00507)Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens), C1QBP GOT2 ERP44 PHB,CC,4,4 of 94,4.49,4.26,0.0001848,0.002186
GO:0005622,intracellular,Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)Q56JX8(Evidence code:IEA/Database source:InterPro:IPR000589)Q58DW5(Evidence code:IEA/Database source:InterPro:IPR005485)Q58DQ3(Evidence code:IEA/Database source:InterPro:IPR000915|I), RPL8 RPS13 RPL5 RPL6,CC,4,4 of 95,4.49,4.21,0.0001922,0.002226
GO:0006613,cotranslational protein targeting to membrane,A6QLP7(Evidence code:IBA/Database source:PANTHER:PTN000309014)Q5EA68(Evidence code:IEA/Database source:UniProtKB:P61619|ens), SSR1 SEC61A1,BP,2,2 of 7,2.25,28.57,0.0002772,0.003145
GO:0008380,RNA splicing,P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508), HNRNPA1 SF3A1 C1QBP DDX39B,BP,4,4 of 106,4.49,3.77,0.0002874,0.003196
GO:0016887,ATPase activity,Q28851(Evidence code:IEA/Database source:UniProtKB:P56134|ens)P05631(Evidence code:IEA/Database source:UniProtKB:P36542|ens)P02721(Evidence code:IEA/Database source:UniProtKB:P18859|ens)P13619(Evidence code:ISS/Database source:UniProtKB:P24539), ATP5J2 ATP5C1 ATP5J ATP5F1,MF,4,4 of 110,4.49,3.64,0.0003291,0.003588
GO:0005794,Golgi apparatus,A7YY49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T133(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A4IFT6(Evidence code:IEA/Database source:UniProtKB:Q9Y3B3|ens)A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9BTV4|ens)P11456(Evidence code:TAS/Database source:), SURF4 TMED9 TMED7 TMEM43 M6PR,CC,5,5 of 202,5.62,2.48,0.0003411,0.003647
GO:0005654,nucleoplasm,Q3SZF3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC44(Evidence code:IEA/Database source:UniProtKB:Q99729|ens)P23004(Evidence code:IEA/Database source:UniProtKB:P22695|ens)Q3SZI8(Evidence code:IEA/Database source:UniProtKB:A0A0A0MT83)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)P13619(Evidence code:IEA/Database source:UniProtKB:P24539|ens), HNRNPH2 HNRNPAB UQCRC2 IVD PHB ATP5F1,CC,6,6 of 315,6.74,1.9,0.0003555,0.00373
GO:0005747,mitochondrial respiratory chain complex I,P23935(Evidence code:IEA/Database source:UniProtKB:Q16718|ens)P42029(Evidence code:IEA/Database source:InterPro:IPR016680)P52505(Evidence code:IDA/Database source:), NDUFA5 NDUFA8 NDUFAB1,CC,3,3 of 46,3.37,6.52,0.0003697,0.003807
GO:0000122,negative regulation of transcription by RNA polymerase II,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens)Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens), H2AFY PRMT6 C1QBP PHB,BP,4,4 of 115,4.49,3.48,0.0003872,0.003914
GO:0005537,mannose binding,Q8MJ82(Evidence code:IEA/Database source:InterPro:IPR033085)P11456(Evidence code:IEA/Database source:InterPro:IPR000296), lman1 M6PR,MF,2,2 of 9,2.25,22.22,0.0004218,0.004188
GO:0006397,mRNA processing,P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507), HNRNPA1 DDX39B C1QBP SF3A1,BP,4,4 of 123,4.49,3.25,0.0004948,0.004826
GO:0090023,positive regulation of neutrophil chemotaxis,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021)Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens), C1QBP C5AR1,BP,2,2 of 10,2.25,20,0.0005052,0.004843
GO:0046872,metal ion binding,P00125(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P35466(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P23004(Evidence code:IEA/Database source:InterPro:IPR011249)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00428(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00426(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P31800(Evidence code:IEA/Database source:InterPro:IPR011249), CYC1 ACAT1 LETM1 CYCS S100A4 UQCRC2 SAMHD1 COX5B COX5A CAT UQCRC1,MF,11,11 of 1125,12.36,0.98,0.0005807,0.005472
GO:0042254,ribosome biogenesis,Q2TBQ5(Evidence code:IEA/Database source:InterPro:IPR004037)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0690), RPL7A C1QBP,BP,2,2 of 11,2.25,18.18,0.000596,0.005523
GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",P42029(Evidence code:IEA/Database source:InterPro:IPR016680)P52505(Evidence code:TAS/Database source:), NDUFA8 NDUFAB1,BP,2,2 of 12,2.25,16.67,0.000694,0.006326
GO:0015078,proton transmembrane transporter activity,P02721(Evidence code:IEA/Database source:InterPro:IPR008387|I)P13619(Evidence code:IEA/Database source:InterPro:IPR008688|I)P13620(Evidence code:IEA/Database source:InterPro:IPR008689|I), ATP5J ATP5F1 ATP5H,MF,3,3 of 61,3.37,4.92,0.0008098,0.007262
GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,A7YY49(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T133(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SURF4 TMED9,CC,2,2 of 14,2.25,14.29,0.0009117,0.007921
GO:0000470,maturation of LSU-rRNA,Q5E9E6(Evidence code:IBA/Database source:PANTHER:PTN000559990)Q2TBQ5(Evidence code:IBA/Database source:PANTHER:PTN000559990), RPL10A RPL7A,BP,2,2 of 14,2.25,14.29,0.0009117,0.007921
GO:0009060,aerobic respiration,P31800(Evidence code:IBA/Database source:PANTHER:PTN000220240)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens), UQCRC1 CAT,BP,2,2 of 17,2.25,11.76,0.001292,0.01105
GO:0006635,fatty acid beta-oxidation,Q58DM8(Evidence code:ISS/Database source:UniProtKB:P30084)Q29RZ0(Evidence code:IBA/Database source:PANTHER:PTN000432120), ECHS1 ACAT1,BP,2,2 of 18,2.25,11.11,0.001433,0.01207
GO:0005681,spliceosomal complex,Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747), DDX39B SF3A1 HNRNPA1,CC,3,3 of 76,3.37,3.95,0.001489,0.01235
GO:0043022,ribosome binding,Q0VCA3(Evidence code:IEA/Database source:InterPro:IPR033122)Q5EA68(Evidence code:IEA/Database source:UniProtKB:P61620|ens), LETM1 SEC61A1,MF,2,2 of 19,2.25,10.53,0.001581,0.01292
GO:0006754,ATP biosynthetic process,P05631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0066)Q28851(Evidence code:IEA/Database source:UniProtKB-KW:KW-0066), ATP5C1 ATP5J2,BP,2,2 of 25,2.25,8,0.002612,0.02075
GO:0004222,metalloendopeptidase activity,P31800(Evidence code:IBA/Database source:PANTHER:PTN000220169)P23004(Evidence code:IEA/Database source:InterPro:IPR001431), UQCRC1 UQCRC2,MF,2,2 of 25,2.25,8,0.002612,0.02075
GO:0008270,zinc ion binding,F1MXI4(Evidence code:IEA/Database source:InterPro:IPR003604)P23004(Evidence code:IBA/Database source:PANTHER:PTN000220169)P31800(Evidence code:IBA/Database source:PANTHER:PTN000220169)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3), MATR3 UQCRC2 UQCRC1 SAMHD1,MF,4,4 of 207,4.49,1.93,0.003174,0.02127
GO:0007005,mitochondrion organization,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1)O02691(Evidence code:IEA/Database source:UniProtKB:Q99714|ens), PHB STOML2 HSD17B10,BP,3,3 of 104,3.37,2.88,0.003521,0.02127
GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",P31039(Evidence code:IEA/Database source:InterPro:IPR011281|I)Q3SZI8(Evidence code:IEA/Database source:InterPro:IPR006091|I), SDHA IVD,MF,2,2 of 29,2.25,6.9,0.003434,0.02127
GO:0008137,NADH dehydrogenase (ubiquinone) activity,P23935(Evidence code:IEA/Database source:UniProtKB:Q9CPP6|ens)P52505(Evidence code:TAS/Database source:), NDUFA5 NDUFAB1,MF,2,2 of 26,2.25,7.69,0.002808,0.02127
GO:0050660,flavin adenine dinucleotide binding,P31039(Evidence code:IEA/Database source:InterPro:IPR011281|I)Q3SZI8(Evidence code:IEA/Database source:InterPro:IPR013786|I), SDHA IVD,MF,2,2 of 32,2.25,6.25,0.00412,0.02127
GO:0000027,ribosomal large subunit assembly,Q58DQ3(Evidence code:IBA/Database source:PANTHER:PTN000076315)Q58DW5(Evidence code:IBA/Database source:PANTHER:PTN000601661), RPL6 RPL5,BP,2,2 of 31,2.25,6.45,0.003885,0.02127
GO:0019843,rRNA binding,Q3T0S6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)Q58DW5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699), RPL8 RPL5,MF,2,2 of 33,2.25,6.06,0.004362,0.02127
GO:0051092,positive regulation of NF-kappaB transcription factor activity,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens), DDRGK1 CAT,BP,2,2 of 35,2.25,5.71,0.004864,0.02127
GO:0005635,nuclear envelope,A5PJQ6(Evidence code:IEA/Database source:UniProtKB:O15173|ens)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PGRMC2 LRRC59,CC,2,2 of 28,2.25,7.14,0.003219,0.02127
GO:0006888,ER to Golgi vesicle-mediated transport,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)Q8MJ82(Evidence code:IEA/Database source:InterPro:IPR033085), BCAP31 lman1,BP,2,2 of 32,2.25,6.25,0.00412,0.02127
GO:0005788,endoplasmic reticulum lumen,Q3T0L2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9DBS1|ens), ERP44 TMEM43,CC,2,2 of 34,2.25,5.88,0.00461,0.02127
GO:0071763,nuclear membrane organization,A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9BTV4|ens),TMEM43,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004611,phosphoenolpyruvate carboxykinase activity,F1MDS3(Evidence code:IEA/Database source:InterPro:IPR008209|I),PCK2,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0045155,"electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity",P00125(Evidence code:IBA/Database source:PANTHER:PTN002231577),CYC1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0010876,lipid localization,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q99JB2),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0008832,dGTPase activity,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710),SAMHD1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0001850,complement component C3a binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004353,glutamate dehydrogenase [NAD(P)+] activity,P00366(Evidence code:IEA/Database source:EC:1.4.1.3),GLUD1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0046356,acetyl-CoA catabolic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0046952,ketone body catabolic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0039536,negative regulation of RIG-I signaling pathway,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0070612,histone methyltransferase activity (H2A-R3 specific),Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0031871,proteinase activated receptor binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0070901,mitochondrial tRNA methylation,O02691(Evidence code:ISS/Database source:UniProtKB:Q99714),HSD17B10,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004046,aminoacylase activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0032567,dGTP binding,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004613,phosphoenolpyruvate carboxykinase (GTP) activity,F1MDS3(Evidence code:IEA/Database source:InterPro:IPR018091),PCK2,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:1900210,positive regulation of cardiolipin metabolic process,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0002037,negative regulation of L-glutamate import across plasma membrane,Q5E9M1(Evidence code:ISS/Database source:UniProtKB:Q8R5J9),ARL6IP5,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:1902860,propionyl-CoA biosynthetic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0009061,anaerobic respiration,P31039(Evidence code:IBA/Database source:PANTHER:PTN000180228),SDHA,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0019919,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine",Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0048205,COPI coating of Golgi vesicle,Q3T133(Evidence code:ISS/Database source:UniProtKB:Q9BVK6),TMED9,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0070611,histone methyltransferase activity (H3-R2 specific),Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0090297,positive regulation of mitochondrial DNA replication,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:1905394,retromer complex binding,P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens),M6PR,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0071723,lipopeptide binding,Q1L1H6(Evidence code:IBA/Database source:PANTHER:PTN000422284),CD1B3,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0000274,"mitochondrial proton-transporting ATP synthase, stator stalk",P13620(Evidence code:IBA/Database source:PANTHER:PTN000294648),ATP5H,CC,1,1 of 1,1.12,100,0.005548,0.02127
GO:0046061,dATP catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,Q5E9M1(Evidence code:IEA/Database source:UniProtKB:O75915|ens),ARL6IP5,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0045153,"electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity",P00125(Evidence code:IBA/Database source:PANTHER:PTN002231577),CYC1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0007549,dosage compensation,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0034970,histone H3-R2 methylation,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0030984,kininogen binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0009245,lipid A biosynthetic process,P52505(Evidence code:IBA/Database source:PANTHER:PTN000466551),NDUFAB1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0006203,dGTP catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0016793,triphosphoric monoester hydrolase activity,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710),SAMHD1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0005757,mitochondrial permeability transition pore complex,P45879(Evidence code:ISS/Database source:UniProtKB:P21796),VDAC1,CC,1,1 of 1,1.12,100,0.005548,0.02127
GO:0050847,progesterone receptor signaling pathway,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0046784,viral mRNA export from host cell nucleus,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:1900116,extracellular negative regulation of signal transduction,Q148K7(Evidence code:IEA/Database source:GO:0048019),LRPAP1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:1901165,positive regulation of trophoblast cell migration,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0033128,negative regulation of histone phosphorylation,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0015578,mannose transmembrane transporter activity,P11456(Evidence code:IEA/Database source:InterPro:IPR000296),M6PR,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:2000002,negative regulation of DNA damage checkpoint,Q3T147(Evidence code:ISS/Database source:UniProtKB:Q13838),DDX39B,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0010385,double-stranded methylated DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0010918,positive regulation of mitochondrial membrane potential,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0070973,protein localization to endoplasmic reticulum exit site,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens),BCAP31,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0001851,complement component C3b binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0039019,pronephric nephron development,Q5EA68(Evidence code:ISS/Database source:UniProtKB:P61620),SEC61A1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:2000323,negative regulation of glucocorticoid receptor signaling pathway,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:1990046,stress-induced mitochondrial fusion,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q99JB2),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0006552,leucine catabolic process,Q3SZI8(Evidence code:IEA/Database source:UniPathway:UPA00363),IVD,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0005721,pericentric heterochromatin,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,CC,1,1 of 1,1.12,100,0.005548,0.02127
GO:0032623,interleukin-2 production,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q99JB2),STOML2,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0005740,mitochondrial envelope,P00428(Evidence code:IEA/Database source:InterPro:IPR002124|I),COX5B,CC,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004108,citrate (Si)-synthase activity,Q29RK1(Evidence code:IEA/Database source:InterPro:IPR010109),CS,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0030283,testosterone dehydrogenase [NAD(P)] activity,O02691(Evidence code:IEA/Database source:EC:1.1.1.51),HSD17B10,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0047015,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,O02691(Evidence code:IEA/Database source:EC:1.1.1.178),HSD17B10,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:1903721,positive regulation of I-kappaB phosphorylation,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6),DDRGK1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0004352,glutamate dehydrogenase (NAD+) activity,P00366(Evidence code:ISS/Database source:UniProtKB:P00367),GLUD1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0003985,acetyl-CoA C-acetyltransferase activity,Q29RZ0(Evidence code:IEA/Database source:EC:2.3.1.9),ACAT1,MF,1,1 of 1,1.12,100,0.005548,0.02127
GO:0005639,integral component of nuclear inner membrane,A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9DBS1|ens),TMEM43,CC,1,1 of 1,1.12,100,0.005548,0.02127
GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0060339,negative regulation of type I interferon-mediated signaling pathway,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,1.12,100,0.005548,0.02127
GO:0051028,mRNA transport,P09867(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509), HNRNPA1 DDX39B,BP,2,2 of 40,2.25,5,0.006229,0.02372
GO:0050821,protein stabilization,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00), PHB CREBL2,BP,2,2 of 47,2.25,4.26,0.008397,0.02457
GO:0000398,"mRNA splicing, via spliceosome",A2VDN6(Evidence code:ISS/Database source:UniProtKB:Q15459)Q3T147(Evidence code:ISS/Database source:UniProtKB:Q13838), SF3A1 DDX39B,BP,2,2 of 43,2.25,4.65,0.007122,0.02457
GO:0007204,positive regulation of cytosolic calcium ion concentration,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752), BCAP31 C5AR1,BP,2,2 of 44,2.25,4.55,0.007432,0.02457
GO:0060326,cell chemotaxis,Q2KIE5(Evidence code:IEA/Database source:GO:0008009)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752), CXCL2 C5AR1,BP,2,2 of 41,2.25,4.88,0.006521,0.02457
GO:0005694,chromosome,Q2HJ65(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158), H2AFY SAMHD1,CC,2,2 of 47,2.25,4.26,0.008397,0.02457
GO:0070374,positive regulation of ERK1 and ERK2 cascade,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens), PHB C5AR1,BP,2,2 of 42,2.25,4.76,0.006819,0.02457
GO:0004096,catalase activity,P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I),CAT,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0043008,ATP-dependent protein binding,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0006550,isoleucine catabolic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:2000510,positive regulation of dendritic cell chemotaxis,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0042101,T cell receptor complex,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,CC,1,1 of 2,1.12,50,0.00831,0.02457
GO:0045917,positive regulation of complement activation,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0010917,negative regulation of mitochondrial membrane potential,Q5E9M1(Evidence code:IEA/Database source:UniProtKB:O75915|ens),ARL6IP5,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0035242,protein-arginine omega-N asymmetric methyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0008177,succinate dehydrogenase (ubiquinone) activity,P31039(Evidence code:IEA/Database source:EC:1.3.5.1),SDHA,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0035241,protein-arginine omega-N monomethyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0004775,succinate-CoA ligase (ADP-forming) activity,Q58DR8(Evidence code:IEA/Database source:EC:6.2.1.5),SUCLG1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0048019,receptor antagonist activity,Q148K7(Evidence code:IEA/Database source:InterPro:IPR038003),LRPAP1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0034184,positive regulation of maintenance of mitotic sister chromatid cohesion,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0032695,negative regulation of interleukin-12 production,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0006533,aspartate catabolic process,P12344(Evidence code:IEA/Database source:UniProtKB:P00505|ens),GOT2,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0000182,rDNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,Q5EA68(Evidence code:IEA/Database source:UniProtKB:P61619|ens),SEC61A1,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0051561,positive regulation of mitochondrial calcium ion concentration,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0048007,"antigen processing and presentation, exogenous lipid antigen via MHC class Ib",Q1L1H6(Evidence code:IBA/Database source:PANTHER:PTN000422284),CD1B3,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0034214,protein hexamerization,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:Q9Z2I0),LETM1,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0001849,complement component C1q binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0097177,mitochondrial ribosome binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:O35658),C1QBP,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0004776,succinate-CoA ligase (GDP-forming) activity,Q58DR8(Evidence code:IEA/Database source:EC:6.2.1.4),SUCLG1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0032494,response to peptidoglycan,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0000035,acyl binding,P52505(Evidence code:IBA/Database source:PANTHER:PTN000466551),NDUFAB1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0047179,platelet-activating factor acetyltransferase activity,P68401(Evidence code:IBA/Database source:PANTHER:PTN000220758),PAFAH1B2,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0032471,negative regulation of endoplasmic reticulum calcium ion concentration,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0043985,histone H4-R3 methylation,Q5E9L5(Evidence code:IEA/Database source:GO:0044020),PRMT6,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0019551,glutamate catabolic process to 2-oxoglutarate,P12344(Evidence code:IEA/Database source:UniProtKB:P05202|ens),GOT2,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0019550,glutamate catabolic process to aspartate,P12344(Evidence code:IEA/Database source:UniProtKB:P05202|ens),GOT2,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0016639,"oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor",P00366(Evidence code:IEA/Database source:InterPro:IPR033922),GLUD1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0031177,phosphopantetheine binding,P52505(Evidence code:IBA/Database source:PANTHER:PTN000466551),NDUFAB1,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0016176,superoxide-generating NADPH oxidase activator activity,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0000389,mRNA 3-splice site recognition,A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333),SF3A1,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0010944,negative regulation of transcription by competitive promoter binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0042288,MHC class I protein binding,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens),BCAP31,MF,1,1 of 2,1.12,50,0.00831,0.02457
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,Q2NL04(Evidence code:IEA/Database source:InterPro:IPR008056),TAPBP,BP,1,1 of 2,1.12,50,0.00831,0.02457
GO:0030285,integral component of synaptic vesicle membrane,A8PVV5(Evidence code:IBA/Database source:PANTHER:PTN000033897),SYPL1,CC,1,1 of 2,1.12,50,0.00831,0.02457
GO:0000139,Golgi membrane,Q3T133(Evidence code:IEA/Database source:GO:0048205)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)A7YY49(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), TMED9 BCAP31 SURF4,CC,3,3 of 147,3.37,2.04,0.008932,0.026
GO:0005741,mitochondrial outer membrane,Q64L89(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)P45879(Evidence code:IEA/Database source:InterPro:IPR001925|I), MGST1 VDAC1,CC,2,2 of 50,2.25,4,0.009416,0.02727
GO:0006915,apoptotic process,P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P45879(Evidence code:ISS/Database source:UniProtKB:P21796), CYCS C1QBP VDAC1,BP,3,3 of 151,3.37,1.99,0.00959,0.02763
GO:0008201,heparin binding,Q148K7(Evidence code:IEA/Database source:InterPro:IPR010483)A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens), LRPAP1 LOC789567,MF,2,2 of 52,2.25,3.85,0.01012,0.02796
GO:0030621,U4 snRNA binding,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0000104,succinate dehydrogenase activity,P31039(Evidence code:ISS/Database source:UniProtKB:P31040),SDHA,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:1903936,cellular response to sodium arsenite,P09867(Evidence code:ISS/Database source:UniProtKB:P09651),HNRNPA1,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0044020,histone methyltransferase activity (H4-R3 specific),Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0060766,negative regulation of androgen receptor signaling pathway,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0000346,transcription export complex,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,CC,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0004300,enoyl-CoA hydratase activity,Q58DM8(Evidence code:IEA/Database source:EC:4.2.1.17),ECHS1,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0046912,"transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer",Q29RK1(Evidence code:IEA/Database source:InterPro:IPR002020|I),CS,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0039534,negative regulation of MDA-5 signaling pathway,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0097038,perinuclear endoplasmic reticulum,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,CC,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0033299,secretion of lysosomal enzymes,P11456(Evidence code:IEA/Database source:UniProtKB:P24668|ens),M6PR,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0003857,3-hydroxyacyl-CoA dehydrogenase activity,O02691(Evidence code:IEA/Database source:EC:1.1.1.35),HSD17B10,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0005787,signal peptidase complex,Q2KI36(Evidence code:IEA/Database source:InterPro:IPR037710),SEC11C,CC,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0045815,"positive regulation of gene expression, epigenetic",Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:1902750,negative regulation of cell cycle G2/M phase transition,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0016446,somatic hypermutation of immunoglobulin genes,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710),SAMHD1,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0005853,eukaryotic translation elongation factor 1 complex,Q5E983(Evidence code:IEA/Database source:InterPro:IPR001326),EEF1B,CC,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0015288,porin activity,P45879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0626),VDAC1,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0015937,coenzyme A biosynthetic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0004069,L-aspartate:2-oxoglutarate aminotransferase activity,P12344(Evidence code:IEA/Database source:EC:2.6.1.1),GOT2,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0006538,glutamate catabolic process,P00366(Evidence code:ISS/Database source:UniProtKB:P00367),GLUD1,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0006532,aspartate biosynthetic process,P12344(Evidence code:IEA/Database source:UniProtKB:P05202|ens),GOT2,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0042789,mRNA transcription by RNA polymerase II,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens),C5AR1,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0008469,histone-arginine N-methyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q6NZB1),PRMT6,MF,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0045730,respiratory burst,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0006627,protein processing involved in protein targeting to mitochondrion,P23004(Evidence code:IBA/Database source:PANTHER:PTN000747147),UQCRC2,BP,1,1 of 3,1.12,33.33,0.01106,0.02796
GO:0005576,extracellular region,Q148K7(Evidence code:IEA/Database source:GO:1900116)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q2KIE5(Evidence code:IEA/Database source:InterPro:IPR001089|I)P46169(Evidence code:IEA/Database source:InterPro:IPR001855|I), LRPAP1 C1QBP CXCL2 DEFB11,CC,4,4 of 300,4.49,1.33,0.01119,0.02816
GO:0005525,GTP binding,F1MDS3(Evidence code:IEA/Database source:InterPro:IPR008209)P00366(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342), PCK2 GLUD1 SAMHD1,MF,3,3 of 165,3.37,1.82,0.01211,0.03033
GO:0001968,fibronectin binding,A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens),LOC789567,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0009264,deoxyribonucleotide catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0016274,protein-arginine N-methyltransferase activity,Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens),PRMT6,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0003847,1-alkyl-2-acetylglycerophosphocholine esterase activity,P68401(Evidence code:IEA/Database source:EC:3.1.1.47),PAFAH1B2,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0006121,"mitochondrial electron transport, succinate to ubiquinone",P31039(Evidence code:IBA/Database source:PANTHER:PTN000180258),SDHA,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0010575,positive regulation of vascular endothelial growth factor production,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:1901612,cardiolipin binding,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0042612,MHC class I protein complex,A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490),BoLA,CC,1,1 of 4,1.12,25,0.01381,0.0316
GO:0043020,NADPH oxidase complex,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,CC,1,1 of 4,1.12,25,0.01381,0.0316
GO:0035246,peptidyl-arginine N-methylation,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q6NZB1),PRMT6,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0008097,5S rRNA binding,Q58DW5(Evidence code:IEA/Database source:InterPro:IPR005485),RPL5,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0071354,cellular response to interleukin-6,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0006068,ethanol catabolic process,P20000(Evidence code:IEA/Database source:UniPathway:UPA00780),ALDH2,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0045471,response to ethanol,P12344(Evidence code:IEA/Database source:UniProtKB:P00505|ens),GOT2,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0016885,"ligase activity, forming carbon-carbon bonds",Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0010759,positive regulation of macrophage chemotaxis,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0005749,"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)",P31039(Evidence code:ISS/Database source:UniProtKB:Q0QF01),SDHA,CC,1,1 of 4,1.12,25,0.01381,0.0316
GO:0009650,UV protection,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0017070,U6 snRNA binding,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,MF,1,1 of 4,1.12,25,0.01381,0.0316
GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",Q58DT1(Evidence code:IBA/Database source:PANTHER:PTN000897517),RPL7,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0042256,mature ribosome assembly,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 4,1.12,25,0.01381,0.0316
GO:0000166,nucleotide binding,P00366(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P45879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547), GLUD1 ETFB VDAC1 SAMHD1 DDX39B SUCLG1,MF,6,6 of 677,6.74,0.89,0.014,0.03191
GO:0006935,chemotaxis,Q673L2(Evidence code:IEA/Database source:InterPro:IPR002234)Q2KIE5(Evidence code:IEA/Database source:InterPro:IPR033899), C5AR1 CXCL2,BP,2,2 of 66,2.25,3.03,0.0157,0.03486
GO:0098869,cellular oxidant detoxification,P00432(Evidence code:IEA/Database source:GO:0004096),CAT,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0008308,voltage-gated anion channel activity,P45879(Evidence code:IEA/Database source:InterPro:IPR001925|I),VDAC1,MF,1,1 of 5,1.12,20,0.01655,0.03486
GO:0030449,regulation of complement activation,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0006614,SRP-dependent cotranslational protein targeting to membrane,Q5EA68(Evidence code:IEA/Database source:UniProtKB:P61619|ens),SEC61A1,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0005688,U6 snRNP,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,CC,1,1 of 5,1.12,20,0.01655,0.03486
GO:1990592,protein K69-linked ufmylation,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6),DDRGK1,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0045261,"proton-transporting ATP synthase complex, catalytic core F(1)",P05631(Evidence code:IEA/Database source:InterPro:IPR000131|I),ATP5C1,CC,1,1 of 5,1.12,20,0.01655,0.03486
GO:0015936,coenzyme A metabolic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0015813,L-glutamate transmembrane transport,Q5E9M1(Evidence code:ISS/Database source:UniProtKB:Q8R5J9),ARL6IP5,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0006085,acetyl-CoA biosynthetic process,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0090398,cellular senescence,Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens),PRMT6,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0006465,signal peptide processing,Q2KI36(Evidence code:IEA/Database source:InterPro:IPR001733|I),SEC11C,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0042744,hydrogen peroxide catabolic process,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0376),CAT,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:1990841,promoter-specific chromatin binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:Q9QZQ8|ens),H2AFY,MF,1,1 of 5,1.12,20,0.01655,0.03486
GO:0035198,miRNA binding,P09867(Evidence code:ISS/Database source:UniProtKB:P09651),HNRNPA1,MF,1,1 of 5,1.12,20,0.01655,0.03486
GO:0006107,oxaloacetate metabolic process,P12344(Evidence code:IEA/Database source:UniProtKB:P05202|ens),GOT2,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0000413,protein peptidyl-prolyl isomerization,Q2YDL5(Evidence code:IEA/Database source:GO:0003755),FKBP11,BP,1,1 of 5,1.12,20,0.01655,0.03486
GO:0035098,ESC/E(Z) complex,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,CC,1,1 of 5,1.12,20,0.01655,0.03486
GO:0005746,mitochondrial respiratory chain,P13184(Evidence code:IEA/Database source:InterPro:IPR003177),COX7A2,CC,1,1 of 5,1.12,20,0.01655,0.03486
GO:0006974,cellular response to DNA damage stimulus,Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q3T147(Evidence code:IBA/Database source:PANTHER:PTN000620148)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3), PRMT6 DDX39B SAMHD1,BP,3,3 of 188,3.37,1.6,0.017,0.03566
GO:0034976,response to endoplasmic reticulum stress,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q80WW9)Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens), DDRGK1 ERP44,BP,2,2 of 70,2.25,2.86,0.01748,0.03655
GO:0045121,membrane raft,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1)P45879(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), STOML2 VDAC1,CC,2,2 of 71,2.25,2.82,0.01794,0.03737
GO:0007283,spermatogenesis,P68401(Evidence code:IEA/Database source:UniProtKB:Q61206|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens), PAFAH1B2 BCAP31,BP,2,2 of 72,2.25,2.78,0.01841,0.03819
GO:0006531,aspartate metabolic process,P12344(Evidence code:ISS/Database source:UniProtKB:P00508),GOT2,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0020027,hemoglobin metabolic process,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0070181,small ribosomal subunit rRNA binding,Q56JX8(Evidence code:IBA/Database source:PANTHER:PTN000223267),RPS13,MF,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0070131,positive regulation of mitochondrial translation,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:O35658),C1QBP,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0034982,mitochondrial protein processing,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q99JB2),STOML2,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0035584,calcium-mediated signaling using intracellular calcium source,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0032689,negative regulation of interferon-gamma production,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0000036,acyl carrier activity,P52505(Evidence code:IBA/Database source:PANTHER:PTN000466551),NDUFAB1,MF,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0006103,2-oxoglutarate metabolic process,P12344(Evidence code:ISS/Database source:UniProtKB:P00508),GOT2,BP,1,1 of 6,1.12,16.67,0.01928,0.0387
GO:0050750,low-density lipoprotein particle receptor binding,Q148K7(Evidence code:IEA/Database source:InterPro:IPR010483|I),LRPAP1,MF,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0050786,RAGE receptor binding,P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens),S100A4,MF,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0000228,nuclear chromosome,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,CC,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0000793,condensed chromosome,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:Q9QZQ8|ens),H2AFY,CC,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0050687,negative regulation of defense response to virus,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0070207,protein homotrimerization,Q64L89(Evidence code:ISS/Database source:UniProtKB:P08011),MGST1,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0051560,mitochondrial calcium ion homeostasis,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202),LETM1,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490),BoLA,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0071004,U2-type prespliceosome,A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333),SF3A1,CC,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0046930,pore complex,P45879(Evidence code:IEA/Database source:UniProtKB-KW:KW-0626),VDAC1,CC,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0033539,fatty acid beta-oxidation using acyl-CoA dehydrogenase,Q2TBV3(Evidence code:ISS/Database source:UniProtKB:P38117),ETFB,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0000245,spliceosomal complex assembly,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,BP,1,1 of 7,1.12,14.29,0.02201,0.04219
GO:0005887,integral component of plasma membrane,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens), BCAP31 C5AR1 PHB,CC,3,3 of 209,3.37,1.44,0.02228,0.04258
GO:0005829,cytosol,P68401(Evidence code:IEA/Database source:UniProtKB:P68402|ens)Q5E9L5(Evidence code:IBA/Database source:PANTHER:PTN000109455)Q3T0B6(Evidence code:IEA/Database source:UniProtKB:Q07021|ens)P52505(Evidence code:IBA/Database source:PANTHER:PTN000466551)Q2TBV3(Evidence code:IBA/Database source:PANTHER:PTN000480375)Q58DQ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PAFAH1B2 PRMT6 C1QBP NDUFAB1 ETFB RPL6,CC,6,6 of 769,6.74,0.78,0.02407,0.04507
GO:0042802,identical protein binding,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P35466(Evidence code:IEA/Database source:UniProtKB:P07091|ens)Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens)P00366(Evidence code:IPI/Database source:UniProtKB:P00366), CAT S100A4 DDX39B GLUD1,MF,4,4 of 379,4.49,1.06,0.02376,0.04507
GO:0031060,regulation of histone methylation,Q2HJ65(Evidence code:IBA/Database source:PANTHER:PTN000755301),H2AFY,BP,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0005540,hyaluronic acid binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,MF,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0005687,U4 snRNP,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,CC,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0019956,chemokine binding,Q6Y1E2(Evidence code:IEA/Database source:UniProtKB:Q04941|ens),PLP2,MF,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0008250,oligosaccharyltransferase complex,Q2KID7(Evidence code:IEA/Database source:UniProtKB:Q9NRP0|ens),OSTC,CC,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0016575,histone deacetylation,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0031690,adrenergic receptor binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:O35796),C1QBP,MF,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0003995,acyl-CoA dehydrogenase activity,Q3SZI8(Evidence code:IEA/Database source:InterPro:IPR006089|I),IVD,MF,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0006541,glutamine metabolic process,P00366(Evidence code:ISS/Database source:UniProtKB:P26443),GLUD1,BP,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0014065,phosphatidylinositol 3-kinase signaling,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0046326,positive regulation of glucose import,Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00),CREBL2,BP,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0003756,protein disulfide isomerase activity,Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens),ERP44,MF,1,1 of 8,1.12,12.5,0.02472,0.04507
GO:0006631,fatty acid metabolic process,Q58DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P52505(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276), ECHS1 NDUFAB1,BP,2,2 of 86,2.25,2.33,0.02542,0.04619
GO:0005528,FK506 binding,Q2YDL5(Evidence code:IBA/Database source:PANTHER:PTN000054102),FKBP11,MF,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0005686,U2 snRNP,A2VDN6(Evidence code:IEA/Database source:UniProtKB:Q15459|ens),SF3A1,CC,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0035710,"CD4-positive, alpha-beta T cell activation",Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q99JB2),STOML2,BP,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0004029,aldehyde dehydrogenase (NAD) activity,P20000(Evidence code:IEA/Database source:EC:1.2.1.3),ALDH2,MF,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0032786,"positive regulation of DNA-templated transcription, elongation",Q3T147(Evidence code:ISS/Database source:UniProtKB:Q13838),DDX39B,BP,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0016239,positive regulation of macroautophagy,P68401(Evidence code:IEA/Database source:UniProtKB:P68402|ens),PAFAH1B2,BP,1,1 of 9,1.12,11.11,0.02743,0.04888
GO:0015934,large ribosomal subunit,Q5E9E6(Evidence code:IEA/Database source:InterPro:IPR002143)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR023672), RPL10A RPL8,CC,2,2 of 92,2.25,2.17,0.02871,0.05099
GO:0048025,"negative regulation of mRNA splicing, via spliceosome",Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 10,1.12,10,0.03013,0.05186
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6),DDRGK1,BP,1,1 of 10,1.12,10,0.03013,0.05186
GO:0030904,retromer complex,P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens),M6PR,CC,1,1 of 10,1.12,10,0.03013,0.05186
GO:0003746,translation elongation factor activity,Q5E983(Evidence code:IEA/Database source:InterPro:IPR001326|I),EEF1B,MF,1,1 of 10,1.12,10,0.03013,0.05186
GO:0035861,site of double-strand break,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,CC,1,1 of 10,1.12,10,0.03013,0.05186
GO:0006342,chromatin silencing,Q2HJ65(Evidence code:IBA/Database source:PANTHER:PTN000604564),H2AFY,BP,1,1 of 10,1.12,10,0.03013,0.05186
GO:0045745,positive regulation of G-protein coupled receptor protein signaling pathway,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 10,1.12,10,0.03013,0.05186
GO:0001772,immunological synapse,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,CC,1,1 of 10,1.12,10,0.03013,0.05186
GO:0045047,protein targeting to ER,Q5EA68(Evidence code:ISS/Database source:UniProtKB:P38377),SEC61A1,BP,1,1 of 10,1.12,10,0.03013,0.05186
GO:0030291,protein serine/threonine kinase inhibitor activity,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 10,1.12,10,0.03013,0.05186
GO:0045814,"negative regulation of gene expression, epigenetic",Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 11,1.12,9.09,0.03282,0.05598
GO:0005791,rough endoplasmic reticulum,Q58DQ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),RPL6,CC,1,1 of 11,1.12,9.09,0.03282,0.05598
GO:0050852,T cell receptor signaling pathway,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 11,1.12,9.09,0.03282,0.05598
GO:0016607,nuclear speck,Q3T147(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN6(Evidence code:IEA/Database source:UniProtKB:A0A024R1K8), DDX39B SF3A1,CC,2,2 of 103,2.25,1.94,0.03514,0.05974
GO:0004364,glutathione transferase activity,Q64L89(Evidence code:IEA/Database source:EC:2.5.1.18),MGST1,MF,1,1 of 12,1.12,8.33,0.03551,0.05983
GO:0007029,endoplasmic reticulum organization,Q5EA68(Evidence code:IEA/Database source:UniProtKB:P61619|ens),SEC61A1,BP,1,1 of 12,1.12,8.33,0.03551,0.05983
GO:0006536,glutamate metabolic process,P12344(Evidence code:ISS/Database source:UniProtKB:P00508),GOT2,BP,1,1 of 12,1.12,8.33,0.03551,0.05983
GO:0016740,transferase activity,Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q64L89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P12344(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808), PRMT6 MGST1 ACAT1 GOT2 CS,MF,5,5 of 633,5.62,0.79,0.03573,0.06002
GO:0006351,"transcription, DNA-templated",Q2TBP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0VD32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804), MYCBP PRMT6 C1QBP CREBL2,BP,4,4 of 435,4.49,0.92,0.03633,0.06084
GO:1901796,regulation of signal transduction by p53 class mediator,Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens),PRMT6,BP,1,1 of 13,1.12,7.69,0.03819,0.06319
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 13,1.12,7.69,0.03819,0.06319
GO:0010501,RNA secondary structure unwinding,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,BP,1,1 of 13,1.12,7.69,0.03819,0.06319
GO:1902882,regulation of response to oxidative stress,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 13,1.12,7.69,0.03819,0.06319
GO:0031492,nucleosomal DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0015908,fatty acid transport,P12344(Evidence code:IEA/Database source:UniProtKB:P00505|ens),GOT2,BP,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0015698,inorganic anion transport,P45879(Evidence code:IEA/Database source:GO:0008308),VDAC1,BP,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0000049,tRNA binding,O02691(Evidence code:ISS/Database source:UniProtKB:Q99714),HSD17B10,MF,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0015297,antiporter activity,Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0050),LETM1,MF,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0008483,transaminase activity,P12344(Evidence code:IEA/Database source:InterPro:IPR000796),GOT2,MF,1,1 of 14,1.12,7.14,0.04086,0.06642
GO:0006355,"regulation of transcription, DNA-templated",Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2TBP7(Evidence code:IEA/Database source:InterPro:IPR026060)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q0VD32(Evidence code:IEA/Database source:InterPro:IPR004827)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens), C1QBP MYCBP PRMT6 CREBL2 PHB,BP,5,5 of 662,5.62,0.76,0.0418,0.06776
GO:0003682,chromatin binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:Q9QZQ8|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens), H2AFY PRMT6,MF,2,2 of 116,2.25,1.72,0.04337,0.06953
GO:0005518,collagen binding,A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens),LOC789567,MF,1,1 of 15,1.12,6.67,0.04352,0.06953
GO:0005684,U2-type spliceosomal complex,A2VDN6(Evidence code:ISS/Database source:UniProtKB:Q15459),SF3A1,CC,1,1 of 15,1.12,6.67,0.04352,0.06953
GO:0006958,"complement activation, classical pathway",Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0180),C1QBP,BP,1,1 of 15,1.12,6.67,0.04352,0.06953
GO:0042054,histone methyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 15,1.12,6.67,0.04352,0.06953
GO:0006520,cellular amino acid metabolic process,P00366(Evidence code:IEA/Database source:InterPro:IPR006095|I)P12344(Evidence code:IEA/Database source:InterPro:IPR000796), GLUD1 GOT2,BP,2,2 of 118,2.25,1.69,0.0447,0.07121
GO:0005504,fatty acid binding,P52505(Evidence code:IDA/Database source:),NDUFAB1,MF,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0043621,protein self-association,A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9DBS1|ens),TMEM43,MF,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0019897,extrinsic component of plasma membrane,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,CC,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0071897,DNA biosynthetic process,Q3T165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0237),PHB,BP,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0005778,peroxisomal membrane,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,CC,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0006094,gluconeogenesis,F1MDS3(Evidence code:IEA/Database source:InterPro:IPR008209|I),PCK2,BP,1,1 of 16,1.12,6.25,0.04618,0.07232
GO:0043065,positive regulation of apoptotic process,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021)Q5E9M1(Evidence code:IEA/Database source:UniProtKB:O75915|ens), C1QBP ARL6IP5,BP,2,2 of 121,2.25,1.65,0.04671,0.07295
GO:0009100,glycoprotein metabolic process,Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens),ERP44,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0045600,positive regulation of fat cell differentiation,Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00),CREBL2,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0008186,RNA-dependent ATPase activity,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,MF,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0002526,acute inflammatory response,Q6QUN5(Evidence code:IEA/Database source:InterPro:IPR039141),TREM1,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0042542,response to hydrogen peroxide,P00432(Evidence code:IBA/Database source:PANTHER:PTN000157250),CAT,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0006406,mRNA export from nucleus,Q3T147(Evidence code:ISS/Database source:UniProtKB:Q13838),DDX39B,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0006986,response to unfolded protein,Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens),ERP44,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0005637,nuclear inner membrane,A6QQR5(Evidence code:IEA/Database source:UniProtKB:Q9DBS1|ens),TMEM43,CC,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0019905,syntaxin binding,Q3T133(Evidence code:IEA/Database source:UniProtKB:Q9BVK6|ens),TMED9,MF,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0030593,neutrophil chemotaxis,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0004004,ATP-dependent RNA helicase activity,Q3T147(Evidence code:IEA/Database source:UniProtKB:Q13838|ens),DDX39B,MF,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0010811,positive regulation of cell-substrate adhesion,A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens),LOC789567,BP,1,1 of 17,1.12,5.88,0.04882,0.07377
GO:0050661,NADP binding,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,MF,1,1 of 18,1.12,5.56,0.05146,0.07671
GO:0032088,negative regulation of NF-kappaB transcription factor activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 18,1.12,5.56,0.05146,0.07671
GO:0070373,negative regulation of ERK1 and ERK2 cascade,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 18,1.12,5.56,0.05146,0.07671
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 18,1.12,5.56,0.05146,0.07671
GO:0006641,triglyceride metabolic process,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 18,1.12,5.56,0.05146,0.07671
GO:0045087,innate immune response,Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399), SAMHD1 C1QBP,BP,2,2 of 131,2.25,1.53,0.05366,0.07874
GO:0004601,peroxidase activity,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0575),CAT,MF,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0008009,chemokine activity,Q2KIE5(Evidence code:IEA/Database source:InterPro:IPR001089|I),CXCL2,MF,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0045177,apical part of cell,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens),C5AR1,CC,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0019882,antigen processing and presentation,A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579),BoLA,BP,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0006909,phagocytosis,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,BP,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,BP,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0042645,mitochondrial nucleoid,Q5E9X4(Evidence code:IEA/Database source:UniProtKB:Q96AG4|ens),LRRC59,CC,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",P20000(Evidence code:IEA/Database source:InterPro:IPR016163),ALDH2,MF,1,1 of 19,1.12,5.26,0.0541,0.07874
GO:0044212,transcription regulatory region DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens)Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens), H2AFY PHB,MF,2,2 of 133,2.25,1.5,0.05509,0.07997
GO:0005811,lipid droplet,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens),BCAP31,CC,1,1 of 20,1.12,5,0.05672,0.0815
GO:0000724,double-strand break repair via homologous recombination,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 20,1.12,5,0.05672,0.0815
GO:0042826,histone deacetylase binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,MF,1,1 of 20,1.12,5,0.05672,0.0815
GO:0016571,histone methylation,Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q96LA8|ens),PRMT6,BP,1,1 of 20,1.12,5,0.05672,0.0815
GO:0006281,DNA repair,Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234), PRMT6 SAMHD1,BP,2,2 of 136,2.25,1.47,0.05726,0.08205
GO:0051897,positive regulation of protein kinase B signaling,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0040029,"regulation of gene expression, epigenetic",Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:1901800,positive regulation of proteasomal protein catabolic process,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6),DDRGK1,BP,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0001650,fibrillar center,P68401(Evidence code:IEA/Database source:UniProtKB:P68402|ens),PAFAH1B2,CC,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0032874,positive regulation of stress-activated MAPK cascade,Q5E9M1(Evidence code:IEA/Database source:UniProtKB:O75915|ens),ARL6IP5,BP,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333),SF3A1,BP,1,1 of 21,1.12,4.76,0.05934,0.08353
GO:0007200,phospholipase C-activating G-protein coupled receptor signaling pathway,Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752),C5AR1,BP,1,1 of 22,1.12,4.55,0.06195,0.08655
GO:0010469,regulation of signaling receptor activity,Q2KIE5(Evidence code:IEA/Database source:GO:0005125),CXCL2,BP,1,1 of 22,1.12,4.55,0.06195,0.08655
GO:0003697,single-stranded DNA binding,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,MF,1,1 of 22,1.12,4.55,0.06195,0.08655
GO:0003676,nucleic acid binding,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)Q3ZC44(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q3T147(Evidence code:IEA/Database source:InterPro:IPR011545)F1MXI4(Evidence code:IEA/Database source:InterPro:IPR000504|I)P09867(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q3SZF3(Evidence code:IEA/Database source:InterPro:IPR000504|I), SAMHD1 HNRNPAB DDX39B MATR3 HNRNPA1 HNRNPH2,MF,6,6 of 989,6.74,0.61,0.0646,0.08958
GO:0015629,actin cytoskeleton,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,CC,1,1 of 23,1.12,4.35,0.06456,0.08958
GO:0007030,Golgi organization,Q3T133(Evidence code:ISS/Database source:UniProtKB:Q9BVK6),TMED9,BP,1,1 of 23,1.12,4.35,0.06456,0.08958
GO:0006629,lipid metabolic process,P68401(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P52505(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q58DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443), PAFAH1B2 NDUFAB1 ECHS1,BP,3,3 of 325,3.37,0.92,0.06536,0.0904
GO:0006325,chromatin organization,Q2HJ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156), H2AFY PRMT6,BP,2,2 of 148,2.25,1.35,0.06622,0.09136
GO:0003755,peptidyl-prolyl cis-trans isomerase activity,Q2YDL5(Evidence code:IEA/Database source:EC:5.2.1.8),FKBP11,MF,1,1 of 24,1.12,4.17,0.06715,0.09196
GO:0098656,anion transmembrane transport,P45879(Evidence code:IEA/Database source:InterPro:IPR001925),VDAC1,BP,1,1 of 24,1.12,4.17,0.06715,0.09196
GO:0030117,membrane coat,Q0V888(Evidence code:IEA/Database source:InterPro:IPR002553),COPG,CC,1,1 of 24,1.12,4.17,0.06715,0.09196
GO:0002376,immune system process,Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391), SAMHD1 BoLA C1QBP,BP,3,3 of 334,3.37,0.9,0.06962,0.09458
GO:0006101,citrate metabolic process,Q29RK1(Evidence code:IEA/Database source:InterPro:IPR010109),CS,BP,1,1 of 25,1.12,4,0.06974,0.09458
GO:0046889,positive regulation of lipid biosynthetic process,Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00),CREBL2,BP,1,1 of 25,1.12,4,0.06974,0.09458
GO:0071901,negative regulation of protein serine/threonine kinase activity,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 25,1.12,4,0.06974,0.09458
GO:0004869,cysteine-type endopeptidase inhibitor activity,Q9BGU1(Evidence code:IEA/Database source:InterPro:IPR000010),BTHRG,MF,1,1 of 26,1.12,3.85,0.07233,0.09784
GO:0016830,carbon-carbon lyase activity,Q29RZ0(Evidence code:IEA/Database source:UniProtKB:P24752|ens),ACAT1,MF,1,1 of 27,1.12,3.7,0.0749,0.1003
GO:0031490,chromatin DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniRule:UR000141801),H2AFY,MF,1,1 of 27,1.12,3.7,0.0749,0.1003
GO:0051781,positive regulation of cell division,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0497),CAT,BP,1,1 of 27,1.12,3.7,0.0749,0.1003
GO:0051287,NAD binding,P20000(Evidence code:ISS/Database source:UniProtKB:Q28399),ALDH2,MF,1,1 of 27,1.12,3.7,0.0749,0.1003
GO:0000786,nucleosome,Q2HJ65(Evidence code:IEA/Database source:InterPro:IPR002119|I),H2AFY,CC,1,1 of 28,1.12,3.57,0.07747,0.103
GO:0007420,brain development,P68401(Evidence code:IBA/Database source:PANTHER:PTN000220758),PAFAH1B2,BP,1,1 of 28,1.12,3.57,0.07747,0.103
GO:0072350,tricarboxylic acid metabolic process,P00366(Evidence code:ISS/Database source:UniProtKB:P26443),GLUD1,BP,1,1 of 28,1.12,3.57,0.07747,0.103
GO:0005856,cytoskeleton,Q5E9M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q32LL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206), ARL6IP5 STOML2,CC,2,2 of 165,2.25,1.21,0.07964,0.1057
GO:1990904,ribonucleoprotein complex,Q2TBQ5(Evidence code:IEA/Database source:InterPro:IPR004037)Q3ZC44(Evidence code:IEA/Database source:UniProtKB:Q99729|ens)P09867(Evidence code:ISS/Database source:UniProtKB:P09651), RPL7A HNRNPAB HNRNPA1,CC,3,3 of 360,3.37,0.83,0.08261,0.1086
GO:0016032,viral process,Q0VD32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945),CREBL2,BP,1,1 of 30,1.12,3.33,0.08258,0.1086
GO:0045454,cell redox homeostasis,Q3T0L2(Evidence code:IEA/Database source:InterPro:IPR013766),ERP44,BP,1,1 of 30,1.12,3.33,0.08258,0.1086
GO:0012505,endomembrane system,A5PJQ6(Evidence code:IBA/Database source:PANTHER:PTN000031541),PGRMC2,CC,1,1 of 30,1.12,3.33,0.08258,0.1086
GO:0048471,perinuclear region of cytoplasm,P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens)P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens), M6PR S100A4,CC,2,2 of 170,2.25,1.18,0.08374,0.1098
GO:0030308,negative regulation of cell growth,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0050830,defense response to Gram-positive bacterium,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0008021,synaptic vesicle,A8PVV5(Evidence code:IEA/Database source:InterPro:IPR001285),SYPL1,CC,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0045766,positive regulation of angiogenesis,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0010951,negative regulation of endopeptidase activity,Q9BGU1(Evidence code:IEA/Database source:GO:0004869),BTHRG,BP,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0042177,negative regulation of protein catabolic process,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 31,1.12,3.23,0.08513,0.1101
GO:0022627,cytosolic small ribosomal subunit,Q56JX8(Evidence code:IBA/Database source:PANTHER:PTN000223267),RPS13,CC,1,1 of 32,1.12,3.12,0.08767,0.1131
GO:0045892,"negative regulation of transcription, DNA-templated",Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8), PHB PRMT6,BP,2,2 of 178,2.25,1.12,0.09041,0.115
GO:0006479,protein methylation,Q5E9L5(Evidence code:IEA/Database source:InterPro:IPR025799),PRMT6,BP,1,1 of 33,1.12,3.03,0.0902,0.115
GO:0003714,transcription corepressor activity,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,MF,1,1 of 33,1.12,3.03,0.0902,0.115
GO:0006334,nucleosome assembly,Q2HJ65(Evidence code:IEA/Database source:InterPro:IPR021171),H2AFY,BP,1,1 of 33,1.12,3.03,0.0902,0.115
GO:0050679,positive regulation of epithelial cell proliferation,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens),C5AR1,BP,1,1 of 33,1.12,3.03,0.0902,0.115
GO:0008203,cholesterol metabolic process,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 33,1.12,3.03,0.0902,0.115
GO:0006260,DNA replication,Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235),SAMHD1,BP,1,1 of 34,1.12,2.94,0.09272,0.1177
GO:0090501,RNA phosphodiester bond hydrolysis,Q0VCA5(Evidence code:IEA/Database source:GO:0004540),SAMHD1,BP,1,1 of 35,1.12,2.86,0.09524,0.1203
GO:0030170,pyridoxal phosphate binding,P12344(Evidence code:IEA/Database source:InterPro:IPR004838|I),GOT2,MF,1,1 of 35,1.12,2.86,0.09524,0.1203
GO:0030176,integral component of endoplasmic reticulum membrane,Q5EA68(Evidence code:ISS/Database source:UniProtKB:P38377),SEC61A1,CC,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0071013,catalytic step 2 spliceosome,A2VDN6(Evidence code:IEA/Database source:UniProtKB:Q15459|ens),SF3A1,CC,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0005777,peroxisome,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0576),CAT,CC,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0033138,positive regulation of peptidyl-serine phosphorylation,Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00),CREBL2,BP,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0005802,trans-Golgi network,P11456(Evidence code:IBA/Database source:PANTHER:PTN000824899),M6PR,CC,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0000302,response to reactive oxygen species,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 36,1.12,2.78,0.09775,0.1219
GO:0016209,antioxidant activity,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,MF,1,1 of 37,1.12,2.7,0.1003,0.1244
GO:0008022,protein C-terminus binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,MF,1,1 of 37,1.12,2.7,0.1003,0.1244
GO:0015031,protein transport,Q0V888(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q5EA68(Evidence code:IEA/Database source:InterPro:IPR002208)Q3T133(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653), COPG SEC61A1 TMED9,BP,3,3 of 394,3.37,0.76,0.101,0.1251
GO:0061077,chaperone-mediated protein folding,Q2YDL5(Evidence code:IBA/Database source:PANTHER:PTN000054102),FKBP11,BP,1,1 of 38,1.12,2.63,0.1027,0.1267
GO:0004540,ribonuclease activity,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,MF,1,1 of 38,1.12,2.63,0.1027,0.1267
GO:0042393,histone binding,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 39,1.12,2.56,0.1052,0.1292
GO:0030198,extracellular matrix organization,A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens),LOC789567,BP,1,1 of 39,1.12,2.56,0.1052,0.1292
GO:0006886,intracellular protein transport,Q0V888(Evidence code:IEA/Database source:InterPro:IPR002553)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417), COPG BCAP31,BP,2,2 of 196,2.25,1.02,0.106,0.1298
GO:0019899,enzyme binding,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens), PHB H2AFY CAT,MF,3,3 of 405,3.37,0.74,0.1073,0.1311
GO:0005770,late endosome,P11456(Evidence code:IEA/Database source:UniProtKB:P24668|ens),M6PR,CC,1,1 of 41,1.12,2.44,0.1102,0.1338
GO:0004386,helicase activity,Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347),DDX39B,MF,1,1 of 41,1.12,2.44,0.1102,0.1338
GO:0016323,basolateral plasma membrane,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens),C5AR1,CC,1,1 of 41,1.12,2.44,0.1102,0.1338
GO:0005509,calcium ion binding,Q0VCA3(Evidence code:IEA/Database source:InterPro:IPR002048)P35466(Evidence code:IEA/Database source:InterPro:IPR001751|I), LETM1 S100A4,MF,2,2 of 203,2.25,0.99,0.1122,0.1359
GO:0008033,tRNA processing,O02691(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819),HSD17B10,BP,1,1 of 43,1.12,2.33,0.1151,0.1389
GO:0051262,protein tetramerization,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 43,1.12,2.33,0.1151,0.1389
GO:0006633,fatty acid biosynthetic process,P52505(Evidence code:IEA/Database source:InterPro:IPR003231),NDUFAB1,BP,1,1 of 44,1.12,2.27,0.1176,0.1406
GO:0000790,nuclear chromatin,Q2HJ65(Evidence code:IEA/Database source:UniRule:UR000141801),H2AFY,CC,1,1 of 44,1.12,2.27,0.1176,0.1406
GO:0050900,leukocyte migration,Q673L2(Evidence code:IBA/Database source:PANTHER:PTN000658787),C5AR1,BP,1,1 of 44,1.12,2.27,0.1176,0.1406
GO:0016485,protein processing,P31800(Evidence code:IBA/Database source:PANTHER:PTN000220169),UQCRC1,BP,1,1 of 44,1.12,2.27,0.1176,0.1406
GO:0006955,immune response,A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579)Q2KIE5(Evidence code:IEA/Database source:InterPro:IPR001089|I), BoLA CXCL2,BP,2,2 of 214,2.25,0.93,0.1222,0.1457
GO:0045271,respiratory chain complex I,P23935(Evidence code:IEA/Database source:UniProtKB:Q9CPP6|ens),NDUFA5,CC,1,1 of 46,1.12,2.17,0.1225,0.1458
GO:0006816,calcium ion transport,Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109),LETM1,BP,1,1 of 47,1.12,2.13,0.1249,0.1484
GO:0006869,lipid transport,P12344(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445),GOT2,BP,1,1 of 51,1.12,1.96,0.1346,0.1589
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens),S100A4,BP,1,1 of 51,1.12,1.96,0.1346,0.1589
GO:0016651,"oxidoreductase activity, acting on NAD(P)H",P23935(Evidence code:IEA/Database source:InterPro:IPR006806),NDUFA5,MF,1,1 of 51,1.12,1.96,0.1346,0.1589
GO:0006508,proteolysis,Q2KI36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P23004(Evidence code:IEA/Database source:InterPro:IPR001431), SEC11C UQCRC2,BP,2,2 of 230,2.25,0.87,0.137,0.1607
GO:0002250,adaptive immune response,Q3T0B6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064),C1QBP,BP,1,1 of 52,1.12,1.92,0.137,0.1607
GO:0032991,protein-containing complex,Q3T0B6(Evidence code:TAS/Database source:),C1QBP,CC,1,1 of 1693,1.12,0.06,0.1367,0.1607
GO:0005769,early endosome,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,CC,1,1 of 55,1.12,1.82,0.1441,0.1687
GO:0045088,regulation of innate immune response,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 56,1.12,1.79,0.1465,0.1708
GO:0022904,respiratory electron transport chain,P23935(Evidence code:IEA/Database source:InterPro:IPR006806),NDUFA5,BP,1,1 of 56,1.12,1.79,0.1465,0.1708
GO:0044877,protein-containing complex binding,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)P42029(Evidence code:IEA/Database source:UniProtKB:P51970|ens), BCAP31 NDUFA8,MF,2,2 of 243,2.25,0.82,0.1493,0.1737
GO:0032259,methylation,Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489),PRMT6,BP,1,1 of 58,1.12,1.72,0.1512,0.1755
GO:0045893,"positive regulation of transcription, DNA-templated",Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens)Q0VD32(Evidence code:ISS/Database source:UniProtKB:Q32M00), PHB CREBL2,BP,2,2 of 255,2.25,0.78,0.1609,0.1856
GO:0051607,defense response to virus,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 62,1.12,1.61,0.1606,0.1856
GO:0003729,mRNA binding,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:O35658),C1QBP,MF,1,1 of 62,1.12,1.61,0.1606,0.1856
GO:0003713,transcription coactivator activity,Q2TBP7(Evidence code:IEA/Database source:InterPro:IPR026060),MYCBP,MF,1,1 of 65,1.12,1.54,0.1676,0.1929
GO:0006486,protein glycosylation,Q2KID7(Evidence code:IEA/Database source:UniPathway:UPA00378),OSTC,BP,1,1 of 66,1.12,1.52,0.1699,0.1947
GO:0016747,"transferase activity, transferring acyl groups other than amino-acyl groups",Q29RZ0(Evidence code:IEA/Database source:InterPro:IPR002155|I),ACAT1,MF,1,1 of 66,1.12,1.52,0.1699,0.1947
GO:0008236,serine-type peptidase activity,Q2KI36(Evidence code:IEA/Database source:InterPro:IPR019756|I),SEC11C,MF,1,1 of 67,1.12,1.49,0.1722,0.197
GO:0016757,"transferase activity, transferring glycosyl groups",Q0V888(Evidence code:IEA/Database source:InterPro:IPR003378),COPG,MF,1,1 of 69,1.12,1.45,0.1768,0.2018
GO:0016874,ligase activity,Q58DR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436),SUCLG1,MF,1,1 of 72,1.12,1.39,0.1836,0.2092
GO:0008168,methyltransferase activity,Q5E9L5(Evidence code:IEA/Database source:InterPro:IPR025799),PRMT6,MF,1,1 of 75,1.12,1.33,0.1904,0.216
GO:0016853,isomerase activity,Q2YDL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413),FKBP11,MF,1,1 of 75,1.12,1.33,0.1904,0.216
GO:0031966,mitochondrial membrane,P52505(Evidence code:IDA/Database source:)P00423(Evidence code:IEA/Database source:UniProtKB:P19783|ens), NDUFAB1 COX4I1,CC,2,2 of 289,2.25,0.69,0.1944,0.2197
GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 77,1.12,1.3,0.1948,0.2197
GO:0045785,positive regulation of cell adhesion,Q3T0B6(Evidence code:ISS/Database source:UniProtKB:Q07021),C1QBP,BP,1,1 of 77,1.12,1.3,0.1948,0.2197
GO:0019216,regulation of lipid metabolic process,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,BP,1,1 of 80,1.12,1.25,0.2015,0.2268
GO:0006952,defense response,P46169(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q2KIE5(Evidence code:IEA/Database source:InterPro:IPR033899), DEFB11 CXCL2,BP,2,2 of 300,2.25,0.67,0.2054,0.2308
GO:0006414,translational elongation,Q5E983(Evidence code:IEA/Database source:InterPro:IPR001326|I),EEF1B,BP,1,1 of 83,1.12,1.2,0.2081,0.2328
GO:0016829,lyase activity,Q58DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456),ECHS1,MF,1,1 of 83,1.12,1.2,0.2081,0.2328
GO:0016042,lipid catabolic process,P68401(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442),PAFAH1B2,BP,1,1 of 84,1.12,1.19,0.2103,0.2343
GO:0005125,cytokine activity,Q2KIE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202),CXCL2,MF,1,1 of 84,1.12,1.19,0.2103,0.2343
GO:0044389,ubiquitin-like protein ligase binding,Q1LZB0(Evidence code:ISS/Database source:UniProtKB:Q96HY6),DDRGK1,MF,1,1 of 85,1.12,1.18,0.2125,0.2358
GO:0016746,"transferase activity, transferring acyl groups",Q29RZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012),ACAT1,MF,1,1 of 85,1.12,1.18,0.2125,0.2358
GO:0006979,response to oxidative stress,P00432(Evidence code:IEA/Database source:InterPro:IPR018028|I),CAT,BP,1,1 of 86,1.12,1.16,0.2147,0.2368
GO:0006820,anion transport,P45879(Evidence code:IEA/Database source:InterPro:IPR030270),VDAC1,BP,1,1 of 86,1.12,1.16,0.2147,0.2368
GO:0042742,defense response to bacterium,P46169(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044),DEFB11,BP,1,1 of 86,1.12,1.16,0.2147,0.2368
GO:0006874,cellular calcium ion homeostasis,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 87,1.12,1.15,0.2169,0.2388
GO:0051260,protein homooligomerization,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:Q9Z2I0),LETM1,BP,1,1 of 88,1.12,1.14,0.219,0.2407
GO:0005765,lysosomal membrane,P11456(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),M6PR,CC,1,1 of 92,1.12,1.09,0.2277,0.2497
GO:0000323,lytic vacuole,P11456(Evidence code:IEA/Database source:InterPro:IPR000296),M6PR,CC,1,1 of 93,1.12,1.08,0.2298,0.251
GO:0005764,lysosome,P11456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458),M6PR,CC,1,1 of 93,1.12,1.08,0.2298,0.251
GO:0006457,protein folding,Q3T0L2(Evidence code:IEA/Database source:UniProtKB:Q9BS26|ens),ERP44,BP,1,1 of 97,1.12,1.03,0.2383,0.2598
GO:0008134,transcription factor binding,Q3T0B6(Evidence code:IEA/Database source:UniProtKB:Q07021|ens),C1QBP,MF,1,1 of 98,1.12,1.02,0.2404,0.2616
GO:0046982,protein heterodimerization activity,Q2HJ65(Evidence code:IEA/Database source:InterPro:IPR009072),H2AFY,MF,1,1 of 103,1.12,0.97,0.2509,0.2724
GO:0019901,protein kinase binding,Q2HJ65(Evidence code:IEA/Database source:UniProtKB:O75367|ens),H2AFY,MF,1,1 of 106,1.12,0.94,0.2571,0.2786
GO:0000981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",Q3T165(Evidence code:IEA/Database source:UniProtKB:P67778|ens),PHB,MF,1,1 of 107,1.12,0.93,0.2591,0.2803
GO:0004930,G-protein coupled receptor activity,Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276),C5AR1,MF,1,1 of 110,1.12,0.91,0.2653,0.2864
GO:0006875,cellular metal ion homeostasis,Q0VCA3(Evidence code:IBA/Database source:PANTHER:PTN000360953),LETM1,BP,1,1 of 111,1.12,0.9,0.2673,0.288
GO:0008285,negative regulation of cell proliferation,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 119,1.12,0.84,0.2834,0.3047
GO:0051259,protein complex oligomerization,Q32LL2(Evidence code:ISS/Database source:UniProtKB:Q9UJZ1),STOML2,BP,1,1 of 120,1.12,0.83,0.2853,0.3063
GO:0006954,inflammatory response,Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752),C5AR1,BP,1,1 of 121,1.12,0.83,0.2873,0.3078
GO:0005102,signaling receptor binding,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422452), CAT BoLA,MF,2,2 of 385,2.25,0.52,0.2917,0.3119
GO:0016787,hydrolase activity,Q2KI36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P68401(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T147(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378), SEC11C SAMHD1 PAFAH1B2 DDX39B,MF,4,4 of 836,4.49,0.48,0.3012,0.3208
GO:0010942,positive regulation of cell death,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 128,1.12,0.78,0.301,0.3208
GO:0048037,cofactor binding,Q58DR8(Evidence code:IEA/Database source:InterPro:IPR003781),SUCLG1,MF,1,1 of 132,1.12,0.76,0.3087,0.3282
GO:0005524,ATP binding,Q3T147(Evidence code:IEA/Database source:InterPro:IPR011545)P00366(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067), DDX39B GLUD1,MF,2,2 of 403,2.25,0.5,0.3099,0.3288
GO:0031012,extracellular matrix,A6H7H3(Evidence code:IEA/Database source:UniProtKB:O70503|ens),LOC789567,CC,1,1 of 137,1.12,0.73,0.3182,0.337
GO:0005515,protein binding,Q0VD32(Evidence code:IPI/Database source:UniProtKB:Q89582)P05631(Evidence code:IPI/Database source:UniProtKB:P00829), CREBL2 ATP5C1,MF,2,2 of 1669,2.25,0.12,0.3294,0.3482
GO:0005975,carbohydrate metabolic process,Q29RK1(Evidence code:IEA/Database source:UniProtKB:O75390|ens),CS,BP,1,1 of 144,1.12,0.69,0.3313,0.3489
GO:0010638,positive regulation of organelle organization,Q3T133(Evidence code:ISS/Database source:UniProtKB:Q9BVK6),TMED9,BP,1,1 of 144,1.12,0.69,0.3313,0.3489
GO:0007275,multicellular organism development,Q5EA68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217),SEC61A1,BP,1,1 of 145,1.12,0.69,0.3332,0.3502
GO:0005768,endosome,P11456(Evidence code:ISS/Database source:UniProtKB:P20645),M6PR,CC,1,1 of 165,1.12,0.61,0.3691,0.3872
GO:0007186,G-protein coupled receptor signaling pathway,Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276|I),C5AR1,BP,1,1 of 168,1.12,0.6,0.3743,0.3919
GO:0009058,biosynthetic process,P12344(Evidence code:IEA/Database source:InterPro:IPR004838|I),GOT2,BP,1,1 of 1113,1.12,0.09,0.3752,0.3921
GO:0016604,nuclear body,Q0VD32(Evidence code:IDA/Database source:),CREBL2,CC,1,1 of 171,1.12,0.58,0.3795,0.3958
GO:0003677,DNA binding,Q0VD32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q2HJ65(Evidence code:IEA/Database source:InterPro:IPR002119|I), CREBL2 H2AFY,MF,2,2 of 481,2.25,0.42,0.3871,0.4031
GO:0055085,transmembrane transport,P45879(Evidence code:IEA/Database source:InterPro:IPR027246),VDAC1,BP,1,1 of 183,1.12,0.55,0.3997,0.4154
GO:0043066,negative regulation of apoptotic process,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 186,1.12,0.54,0.4047,0.4198
GO:0003700,DNA-binding transcription factor activity,Q0VD32(Evidence code:IEA/Database source:InterPro:IPR004827),CREBL2,MF,1,1 of 187,1.12,0.53,0.4063,0.4207
GO:0008289,lipid binding,Q32LL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446),STOML2,MF,1,1 of 190,1.12,0.53,0.4112,0.425
GO:0038023,signaling receptor activity,Q6QUN5(Evidence code:IEA/Database source:InterPro:IPR039141),TREM1,MF,1,1 of 204,1.12,0.49,0.4336,0.4473
GO:0008233,peptidase activity,Q2KI36(Evidence code:IEA/Database source:InterPro:IPR001733),SEC11C,MF,1,1 of 205,1.12,0.49,0.4352,0.4481
GO:0042803,protein homodimerization activity,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,MF,1,1 of 210,1.12,0.48,0.4429,0.4552
GO:0043085,positive regulation of catalytic activity,O77775(Evidence code:IEA/Database source:GO:0016176),NCF2,BP,1,1 of 229,1.12,0.44,0.4714,0.4836
GO:0043231,intracellular membrane-bounded organelle,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)Q64L89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)Q5E9X4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492), CAT MGST1 LRRC59,CC,3,3 of 1927,3.37,0.16,0.4926,0.5044
GO:0006396,RNA processing,A2VDN6(Evidence code:IEA/Database source:InterPro:IPR000061|I),SF3A1,BP,1,1 of 246,1.12,0.41,0.4956,0.5066
GO:0003824,catalytic activity,Q58DR8(Evidence code:IEA/Database source:InterPro:IPR005810|I)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)P12344(Evidence code:IEA/Database source:InterPro:IPR004838|I)Q29RZ0(Evidence code:IEA/Database source:InterPro:IPR016039)P23004(Evidence code:IEA/Database source:InterPro:IPR011249)Q58DM8(Evidence code:IEA/Database source:InterPro:IPR001753|I)P31800(Evidence code:IEA/Database source:InterPro:IPR011249), SUCLG1 SAMHD1 GOT2 ACAT1 UQCRC2 ECHS1 UQCRC1,MF,7,7 of 1952,7.87,0.36,0.5032,0.5134
GO:1903508,positive regulation of nucleic acid-templated transcription,Q2TBP7(Evidence code:IEA/Database source:GO:0003713),MYCBP,BP,1,1 of 255,1.12,0.39,0.508,0.5173
GO:0016192,vesicle-mediated transport,Q0V888(Evidence code:IEA/Database source:InterPro:IPR002553),COPG,BP,1,1 of 277,1.12,0.36,0.537,0.5458
GO:0008152,metabolic process,Q58DR8(Evidence code:IEA/Database source:InterPro:IPR005810|I)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)P20000(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q58DM8(Evidence code:IEA/Database source:InterPro:IPR001753|I)Q29RZ0(Evidence code:IEA/Database source:InterPro:IPR002155|I), SUCLG1 SAMHD1 ALDH2 ECHS1 ACAT1,BP,5,5 of 2613,5.62,0.19,0.5561,0.5642
GO:0046914,transition metal ion binding,P35466(Evidence code:IEA/Database source:InterPro:IPR034325),S100A4,MF,1,1 of 309,1.12,0.32,0.5761,0.5834
GO:0010628,positive regulation of gene expression,Q3T165(Evidence code:IEA/Database source:UniProtKB:P35232|ens),PHB,BP,1,1 of 331,1.12,0.3,0.601,0.6076
GO:0007165,signal transduction,Q673L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807),C5AR1,BP,1,1 of 809,1.12,0.12,0.7284,0.7351
GO:0031090,organelle membrane,Q5E9X4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),LRRC59,CC,1,1 of 830,1.12,0.12,0.73,0.7353
GO:0010468,regulation of gene expression,Q3T147(Evidence code:IBA/Database source:PANTHER:PTN000620148),DDX39B,BP,1,1 of 870,1.12,0.11,0.7338,0.7378
GO:0017076,purine nucleotide binding,F1MDS3(Evidence code:IEA/Database source:InterPro:IPR008210|I),PCK2,MF,1,1 of 576,1.12,0.17,1,1
GO:0005615,extracellular space,Q2KIE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202),CXCL2,CC,1,1 of 426,1.12,0.23,1,1
GO:0030154,cell differentiation,Q0VD32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221),CREBL2,BP,1,1 of 434,1.12,0.23,1,1
